|
시장보고서
상품코드
2129059
ARMET 유사 단백질 1 시장 : 제품 유형별, 용도별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)ARMET-like Protein 1 Market, By Product Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033 |
||||||
ARMET 유사 단백질 1시장 규모는 2025년에 8,470만 달러로 평가되며, 2026년부터 2033년까지 CAGR 8.1%로 확대될 것으로 전망됩니다.
ARMET 유사 단백질 1 시장은 ARMETL1로도 알려진 연구용 등급의 재조합 뇌 도파민 신경 영양 인자(CDNF)로 구성되어 있으며, 이들은 주로 치료용 제제가 아닌 정제된 실험용 시약으로 제공됩니다. 여기에는 전체 길이 단백질, 특정 단편, 태그가 부착된 버전, 박테리아 및 포유류 발현 시스템, 그리고 분석적 순도에 따라 일반적으로 구분되는 기타 변이체가 포함되며, 신경과학, 신경 보호, 신경 신호 전달, 단백질 생물학 및 각종 분석을 대상으로 합니다. 2025년에는 3가지 실험 모델에서 영양 인자 결핍 후 뉴런 생존율이 75% 향상된 것이 실험적으로 입증되어, CDNF의 치료적 유용성을 뒷받침하는 증거가 더욱 축적되었습니다. 이는 품질, 활성, 재현성을 기반으로 한 연구용 제품 선정에 중요한 의미를 지닙니다.
ARMET 유사 단백질 1 시장 - 시장 역학
실험적 증거의 확대가 CDNF 시약의 활용을 촉진
기전에 대한 증거가 증가함에 따라, 기능성 CDNF가 연구 현장에 도입되는 것이 촉진되고 있습니다. 'Journal of Neurochemistry'에 2025년에 게재된 연구에서 나타난 바와 같이, CDNF는 PI3K/AKT/mTOR 신호 전달 경로를 통해 후근 신경절 모델에서 신경 돌기 형성을 촉진하고 뉴런을 보호했습니다. 특히 주목할 점은, 이 성장 인자 치료로 세포 생존율이 46%에서 75%로 개선된 반면, NGF의 경우 77%였다는 점입니다. 또한, 이 조사에서는 비활성형 CDNF-ΔKTEL 돌연변이체의 경우 200 마이크로미터 미만이었던 반면, 신경돌기의 길이가 약 390 마이크로미터로 증가했다는 사실도 보고되었습니다. 전반적으로 이러한 연구 결과는 연구용 등급 재조합 단백질의 신뢰성을 높여, 결과적으로 CDNF 수요 확대에 기여하고 있습니다.
ARMET 유사 단백질 1 시장 - 시장 세분화 분석:
세계 ARMET 유사 단백질 1 시장은 제품 유형, 용도, 최종사용자 및 지역을 기준으로 세분화되어 있습니다.
제품 유형별로는, 불순물이 없고 표준적인 조성을 가지며 적절한 기능을 갖춘 제품을 사용하여 결과를 얻었는지 여부에 따라 연구의 질이 좌우될 가능성이 있으므로, 순도는 ARMET 유사 단백질 1 제품 범주에서 매우 중요한 역할을 합니다. 따라서 순도가 낮은(95% 미만) 제품은 탐색적 실험, 스크리닝 및 연구 대상 물질의 특성을 엄격하게 관리할 필요가 없는 기타 연구 분야에만 사용될 가능성이 있습니다. 반면, 고순도(95% 이상) 제품은 메커니즘 분석, 구조 분석 및 고도의 관리가 필요한 기타 연구에 사용할 수 있습니다. SDS-PAGE 또는 HPLC를 통해 확인된 고순도(95% 이상)의 인간 CDNF 단백질만을 공급하는 기업이 있는 반면, 중간 순도의 경우 순도 수준이 약 85%인 타사 제품이 해당됩니다. 전자는 불순물 함량에 대한 요건을 명확히 지정하고, 필요한 특성에 대해 명확한 생각을 가지고 계신 고객께 바람직한 선택지가 됩니다.
용도별로 보면 연구 기관, 대학, 생명공학 기업 및 수탁 연구 기관(CRO)이 인간 CDNF 단백질의 가장 중요한 최종사용자입니다. 전자의 대표적인 사례는 연구의 질, 재현성, 생물학적 활성의 유무, 그리고 필요한 실험을 수행하기 위한 충분한 공급량에 중점을 둡니다. 한편, 학술 연구 기관은 기초 연구부터 신경 세포와 관련된 특정 응용 분야에 이르기까지 CDNF에 대해 폭넓은 수요를 보이고 있습니다. 생명공학 기업 및 CRO(위탁 연구 기관)는 전임상시험에 관심을 가지고 있어 또 다른 신흥 부문으로 부상하고 있습니다. 2025년에는 리우데자네이루 연방대학교 연구센터의 CDNF가 후근 신경절에 미치는 영향에 관한 연구와, 남서 의과대학의 CDNF 신호 전달 경로에 관한 또 다른 연구 그룹의 연구 결과가 발표될 예정입니다. 따라서 높은 확률로 학술 기관이 계속해서 CDNF 단백질의 최대 최종사용자가 될 것이라고 말할 수 있습니다.
ARMET 유사 단백질 1 시장 - 지역별 분석
북미는 주요 연구 기관, 확립된 신경과학 프로그램, 그리고 재조합 단백질의 광범위한 공급 기반이 융합된 생의학 생태계를 갖추고 있어, ARMET 유사 단백질 1 연구에 유리한 환경을 제공합니다. NIH 데이터에 따르면, 2025년에는 연구 보조금을 통해 자금을 지원받은 수석 연구자가 44,002명(그중 여성 18,100명, 남성 25,902명)에 달하여, 이 지역의 공공 지원을 받는 연구 커뮤니티의 규모를 여실히 보여주고 있습니다. 이러한 인프라는 단백질 생물학과 신경퇴행성 질환 및 신경 질환 간의 연관성을 규명하는 연구를 뒷받침하고 있습니다. 이 지역에 서비스를 제공하는 각 공급업체는 엄격한 순도 사양, 정의된 발현 시스템, 기능 검증 및 기술 문서를 통해 차별화를 꾀하고 있습니다. 그 결과, 북미는 여전히 고품질 CDNF 연구 시약 및 중개 신경과학 실험의 중요한 거점으로 남아 있습니다.
유럽은 확립된 신경과학 서비스, 범유럽적 학술 협력, 그리고 CDNF의 신경 보호 특성에 대한 중개 분석을 통해 계속해서 중요한 역할을 수행하고 있습니다. 2025년, 유럽연구집행청(ERCEA)은 ‘호라이즌 유럽(Horizon Europe)’의 5차례 공모를 통해 3,400건 이상의 제안을 접수했습니다. 이 제안들은 건강 연구를 지원하는 과학 장비 및 서비스를 대상으로 하며, 이 분야는 CDNF 유사체의 치료제 개발로 확대되었습니다. 또한 2025년 1월, 헬싱키 대학교는 저분자 CDNF/MANF 유사체를 검증하는 전임상 개발 연구를 시작했습니다. 이것들이 실제로 사용된 시약의 양을 직접적으로 나타내는 것은 아니지만, CDNF에 대한 관심이 지속되고 있음을 시사하며, 특수 단백질 및 이를 기반으로 한 실험적 응용을 활용한 연구를 수행하기 위한 상당한 조직적 기반이 유럽에 존재함을 보여줍니다.
목차
제1장 ARMET 유사 단백질 1 시장 개요
제2장 주요 요약
제3장 ARMET 유사 단백질 1의 주요 시장 동향
제4장 ARMET 유사 단백질 1 산업 분석
제5장 ARMET 유사 단백질 1 시장 : 높아지는 지정학적 긴장의 영향
제6장 ARMET 유사 단백질 1 시장 구도
제7장 ARMET 유사 단백질 1 시장 : 유형별
제8장 ARMET 유사 단백질 1 시장 : 용도별
제9장 ARMET 유사 단백질 1 시장 : 최종사용자별
제10장 ARMET 유사 단백질 1 시장 : 지역별
제11장 주요 벤더 분석 : ARMET 유사 단백질 1 산업
제12장 AnalystView의 전방위 전망
KSM 26.09.17ARMET-like Protein 1 Market size was valued at US$ 84.7 Million in 2025, expanding at a CAGR of 8.1% from 2026 to 2033.
The ARMET-like Protein 1 market consists of research-grade recombinant cerebral dopamine neurotrophic factor (CDNF), also known as ARMETL1, which is mostly offered as a purified laboratory reagent rather than a therapeutic entity, including full-length protein, specific fragments, tagged versions, bacterial and mammalian expression systems, and other variants that are typically differentiated by analytical purity, targeting neuroscience, neuroprotection, neuronal signaling, protein biology, and various assays. In 2025, experimental evidence demonstrated an increased viability of neurons by 75% following trophic deprivation in three experimental models, expanding a body of evidence supporting the therapeutic utility of CDNF, which has implications for research product selection based on quality, activity, and reproducibility.
ARMET-like Protein 1 Market- Market Dynamics
Expanding Experimental Evidence Is Strengthening CDNF Reagent Utilization
Increasing mechanistic evidence supports the introduction of functional CDNF into research laboratory practice. As shown by a 2025 study published in the Journal of Neurochemistry, CDNF promoted neuritogenesis and protected neurons in dorsal root ganglion models through PI3K/AKT/mTOR signaling. Notably, the growth factor treatment resulted in cell viability rates improving from 46% to 75% as compared to 77% for NGF. In addition, the study also reported increased neurite lengths of about 390 micrometers versus under 200 micrometers for the inactive CDNF-ΔKTEL mutant. Overall, such findings enhance the credibility of research-grade recombinant proteins, thus contributing to the rising demand for CDNF.
ARMET-like Protein 1 Market- Segmentation Analysis:
The Global ARMET-like Protein 1 Market is segmented on the basis of Product Type, Application, End User, and Region.
By product type, purity will play a critical role in the product category of ARMET-like Protein 1 since the quality of research may depend on whether the result was achieved using a product without impurities, with a standard composition, and appropriate functionality. Thus, products with low purity (>95%) may only be used for exploratory testing, screening, and other research areas that do not require strict control over the properties of the substance under study. At the same time, items with high purity (>95%) may be used for mechanistic and structural analysis as well as other studies requiring a high level of control. Companies only offer human CDNF protein with high (>95%) purity, which is confirmed by SDS-PAGE or HPLC, while medium purity is represented by products from other companies with a purity level of approximately 85%. The former is a preferred choice among customers who specify their requirements in terms of impurity content and have a clear idea of the characteristics they need.
By application, research centers, universities, biotechnology companies, and contract research organizations are the most significant end users of human CDNF protein. Representatives of the first category focus on the quality of research, its reproducibility, the presence of biological activity, and sufficient supply to conduct the necessary experiments. Academic research sites, on the other hand, reflect a wide range of needs in terms of CDNF, from fundamental research to specific applications related to neurons. Biotechnology companies and contract research organizations represent another emerging segment, as they are interested in preclinical studies. In 2025, research conducted by the research center of the Federal University of Rio de Janeiro investigating the effect of CDNF on the dorsal root ganglion and a separate group from Southwest Medical University studying the signaling pathway of CDNF will be published. Thus, with a high degree of certainty academic institutions remain the largest end users of CDNF protein.
ARMET-like Protein 1 Market- Geographical Insights
North America offers a favorable environment for ARMET-like Protein 1 research because its biomedical ecosystem combines major research institutions, established neuroscience programs, and a broad supplier base for recombinant proteins. NIH data recorded 44,002 principal investigators funded through research grants in 2025, including 18,100 women and 25,902 men, illustrating the scale of the region's publicly supported research community. This infrastructure supports investigations linking protein biology with neurodegenerative and neurological disorders. Suppliers serving the region differentiate through stringent purity specifications, defined expression systems, functional validation, and technical documentation. North America consequently remains an important center for premium CDNF research reagents and translational neuroscience experimentation.
Europe continues to be relevant through established neuroscience services, pan-European academic cooperation, and translational analysis of the neuroprotective properties of CDNF. In 2025, the European Research Executive Agency accepted more than 3,400 proposals throughout 5 calls on Horizon Europe, covering scientific instruments/services in support of health research; the field extended toward the therapeutic development of CDNF analogs, and in January 2025, the University of Helsinki launched a preclinical development study examining small-molecule CDNF/MANF analogs. These are not measures of the actual quantities of reagent used, but they suggest that interest in CDNF continues and indicate a sizable European organizational base for research using specialized proteins and experimental applications based on them.
ARMET-like Protein 1 Market- Competitive Landscape:
The competitive landscape in the field of life-science reagent is fragmented, where vendors offering similar products differentiate from one another by providing various expression platforms, construct engineering, molecular tags, endotoxin levels, purity, functional validation, and application support, rather than a dominant Protein 1 franchise of the ARMET-like. Abcam, for instance, provides more than one human CDNF protein with an endotoxin level below 0.01 EU/mg and over 95% purity, while Proteintech offers ARMETL1 recombinant protein with bacterial expression systems and the availability of custom order options. Other suppliers also provide HEK293-expressed and His-tagged or Fc-tagged proteins with the option of choosing between different tags and expression systems according to particular research needs. his product diversity places greater emphasis on reproducibility, lot consistency, technical documentation, and application-specific validation. Supplier credibility and technical support therefore will be key consideration when a laboratory chooses a particular supplier.
Recent Developments:
In January 2025, Herantis Pharma reported findings from the HER-096 Phase 1a first-in-human study in 60 healthy volunteers demonstrating blood-brain-barrier penetration data in their development.
In August 2025, scientists from the Federal University of Rio de Janeiro released study results indicating CDNF promoted neuritogenesis and neuroprotection of dorsal root ganglion neurons via the PI3K/AKT/mTOR signaling pathway.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ARMET-LIKE PROTEIN 1 MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbexa Ltd
- MyBioSource
- Alomone Labs
- Antibodies.com
- Sigma-Aldrich
- Syd Labs
- Abcam
- Thermo Fisher Scientific
- Novus Biologicals
- Bio-Techne (R&D Systems)
- Cell Signaling Technology
- Proteintech Group
- GeneTex
- Biorbyt
- Cusabio
- Others
GLOBAL ARMET-LIKE PROTEIN 1 MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Purity<95%
- Purity >=95%
GLOBAL ARMET-LIKE PROTEIN 1 MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Research Center
- University
- Others
GLOBAL ARMET-LIKE PROTEIN 1 MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Academic & research institutes
- Contract research organizations (CROs)
- Pharmaceutical & biotech companies
- Diagnostic laboratories
- Others
GLOBAL ARMET-LIKE PROTEIN 1 MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Table of Contents
1. ARMET-like Protein 1 Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. ARMET-like Protein 1 Market Snippet by Type
- 2.1.2. ARMET-like Protein 1 Market Snippet by Application
- 2.1.3. ARMET-like Protein 1 Market Snippet by End User
- 2.1.4. ARMET-like Protein 1 Market Snippet by Country
- 2.1.5. ARMET-like Protein 1 Market Snippet by Region
- 2.2. Competitive Insights
3. ARMET-like Protein 1 Key Market Trends
- 3.1. ARMET-like Protein 1 Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. ARMET-like Protein 1 Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. ARMET-like Protein 1 Market Opportunities
- 3.4. ARMET-like Protein 1 Market Future Trends
4. ARMET-like Protein 1 Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. ARMET-like Protein 1 Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. ARMET-like Protein 1 Market Landscape
- 6.1. ARMET-like Protein 1 Market Share Analysis, 2025
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. ARMET-like Protein 1 Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
- 7.1.2. Purity<95%
- 7.1.3. Purity >=95%
8. ARMET-like Protein 1 Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 8.1.2. Research Center
- 8.1.3. University
- 8.1.4. Others
9. ARMET-like Protein 1 Market - By End User
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
- 9.1.2. Academic & research institutes
- 9.1.3. Contract research organizations (CROs)
- 9.1.4. Pharmaceutical & biotech companies
- 9.1.5. Diagnostic laboratories
- 9.1.6. Others
10. ARMET-like Protein 1 Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. ARMET-like Protein 1 Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. ARMET-like Protein 1 Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.8. UK
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.8.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.9. France
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.9.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.10. Italy
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.10.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.11. Spain
- 10.3.11.1. Overview
- 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.11.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.12. The Netherlands
- 10.3.12.1. Overview
- 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Overview
- 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.14. Russia
- 10.3.14.1. Overview
- 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.14.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.15. Poland
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.15.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.16. Denmark
- 10.3.16.1. Overview
- 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.16.3. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.17. Rest of Europe
- 10.3.17.1. Overview
- 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. ARMET-like Protein 1 Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.7. China
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.7.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.8. India
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.8.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.12. Indonesia
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.13. Thailand
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.13.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.15. Taiwan
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.15.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.16. Vietnam
- 10.4.16.1. Overview
- 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.16.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.17. Rest of APAC
- 10.4.17.1. Overview
- 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. ARMET-like Protein 1 Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. ARMET-like Protein 1 Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.8. UAE
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.8.3. UAE Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.13. Iran
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.13.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.14. Qatar
- 10.6.14.1. Overview
- 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.14.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.15. Rest of MEA
- 10.6.15.1. Overview
- 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
- 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11. Key Vendor Analysis- ARMET-like Protein 1 Industry
- 11.1. Competitive Benchmarking
- 11.1.1. Competitive Dashboard
- 11.1.2. Competitive Positioning
- 11.2. Company Profiles
- 11.2.1. Abbexa Ltd
- 11.2.2. MyBioSource
- 11.2.3. Alomone Labs
- 11.2.4. Antibodies.com
- 11.2.5. Sigma-Aldrich
- 11.2.6. Syd Labs
- 11.2.7. Abcam
- 11.2.8. Thermo Fisher Scientific
- 11.2.9. Novus Biologicals
- 11.2.10. Bio-Techne (R&D Systems)
- 11.2.11. Cell Signaling Technology
- 11.2.12. Proteintech Group
- 11.2.13. GeneTex
- 11.2.14. Biorbyt
- 11.2.15. Cusabio
- 11.2.16. Others
12. 360 Degree AnalystView
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
